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OBJECTIVE — To compare the effects of a eucaloric diet higher in carbohydrate/lower in fat
versus lower in carbohydrate/higher in monounsaturated fat on postmeal triglyceride (TG)
concentrations and other cardiovascular disease risk factors in nonobese subjects with type 1
diabetes and in good glycemic control.
RESEARCH DESIGN AND METHODS — In a parallel group design study, 30 subjects
were randomly assigned and completed one of the two eucaloric diets. Assessments included:
BMI, blood pressure, A1C, plasma lipids, and markers of oxidation, thrombosis, and inﬂamma-
tion. At 6 months, subjects were hospitalized for 24 h to measure plasma TG excursions.
RESULTS — There were no signiﬁcant differences between groups other than decreased
plasminogen activator inhibitor 1 (PAI-1) levels and weight gain in the lower-carbohydrate/
higher–monounsaturated fat group. During the 24-h testing, the lower-carbohydrate/higher–
monounsaturated fat group had a lower plasma TG proﬁle.
CONCLUSIONS — A diet lower in carbohydrate/higher in monounsaturated fat could offer an
appropriatechoicefornonobesetype1diabeticindividualswithgoodmetabolicandweightcontrol.
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T
he optimal macronutrient composi-
tion of the diet in diabetes has not
yetbeenestablished.Dietaryrecom-
mendations for carbohydrates range from
45–60%ofenergyintakeand25–35%for
fat (1–2); the amount of carbohydrates is
usually inversely associated with amount
of fat. On the one hand, higher amounts
of carbohydrates are directly associated
withincreasesinplasmatriglyceride(TG)
levels and postprandial glycemic levels
(3),riskfactorsinthedevelopmentofmi-
cro- and macrovascular complications in
diabetes (4–5). On the other hand, high-
er-fat diets have the potential to increase
fasting and postprandial TG levels, inde-
pendent risk factors for macroangiopathy
(5). Thus, nutrition therapy needs to ad-
dress the effects of diet on both fasting
and postprandial TG and glycemic levels.
Intype2diabetes,replacingcarbohy-
drates with monounsaturated fats in eu-
caloricdietswasassociatedwithlowerTG
levelsandimprovedglycemiccontrol(6–
7); however, results are contradictory in
type 1 diabetes (8–9). Therefore, our ob-
jective was to compare the effects of a eu-
caloric diet, higher in carbohydrate/lower
infatversuslowerincarbohydrate/higher
in monounsaturated fat, on 24-h TG and
glycemic excursions and other cardiovas-
cular risk factors in type 1 diabetes. We
expected that: 1) the lower carbohydrate
content of the higher–monounsaturated
fat diet would reduce VLDL-TG produc-
tion, resulting in lower fasting TG levels
and 24-h TG area under the curve, in line
withtype2diabetesstudies(6–7);and,2)
the higher monounsaturated fat intake
wouldpositivelyaffectLDLoxidation,ad-
hesion molecules, and markers of throm-
bosis and inﬂammation (10–12).
RESEARCH DESIGN AND
METHODS— Adults with type 1 dia-
betes on intensive insulin therapy were
recruited. Exclusion criteria included
BMI 30 kg/m
2, A1C 8.4%, and major
diabetes complications. The project re-
ceived ethics approval (2003–2007).
In this 6-month parallel group design
study, subjects were randomly assigned
to follow a eucaloric diet higher in carbo-
hydrate/lower in fat or lower in carbohy-
drate/higher in monounsaturated fat:
54–57% and 43–46% carbohydrates,
27–30% and 37–40% total fat (10 and
20% monounsaturated), respectively.
Saturatedfat(10%)andﬁber(25g/day)
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carbohydrate/higher-fat diet had fewer
starch and more fat choices in the form of
olive oil.
On a weekly basis a dietitian moni-
tored subjects dietary intake (24-h tele-
phone food recall), premeal glycemia,
dietary carbohydrate meal content, and
insulin doses administered. Subjects re-
corded daily glycemic levels, insulin
doses, grams of mealtime carbohydrates,
and hypoglycemic events.
Baseline and 6-month measurements
includedBMI,bloodpressure,A1C,plasma
lipids, adhesion molecules, and markers of
oxidation, thrombosis, and inﬂammation.
At 6 months, subjects were hospitalized for
24 h to monitor TG and glycemic excur-
sions.Mealswerestandardizedaccordingto
diet assignment: breakfast and lunch were
similar for the two groups, and differences
in carbohydrate/fat contents were achieved
atthesuppermeal.Usualprescribedinsulin
dosesweregivenandtookintoaccountpre-
meal glycemia and carbohydrate meal
content.
Mann-Whitney tests were used to
compare values between the two diets,
and Wilcoxon’s signed-rank tests were
used to compare values within each diet
group, since many variables did not meet
the normality assumption of the t test.
Signiﬁcance was set as P  0.05.
RESULTS— Thirty individuals com-
pleted the study, and baseline character-
istics were similar between the two study
groups: mean age 37.9  8.1 years, years
since diagnosis 16.5  10.6, BMI 24.3 
2.6 kg/m
2, A1C 7.2  0.7%, dietary car-
bohydrates 45.5  10.7%, total fat
36.9  10.5%, monounsaturated fat
15.5  5.7%, and saturated fat 11.7 
4.3%. The carbohydrate intake of our
subjects was similar to that of the sub-
jects in the Diabetes Control and Com-
plications Trial (DCCT) intensive-
treated group (13). During the 6-month
trial, subjects followed their diet pre-
scriptions (based on 24-h recalls) and
appropriately assessed carbohydrate in-
take at meals ( 10%) for insulin dose
adjustments. There were no differences
between groups for insulin doses, gly-
cemic levels, and hypo- and hypergly-
cemic episodes.
Clinical and biochemical results (Ta-
ble 1) indicate no signiﬁcant differences
betweenthetwogroupsatbaselineandat
6 months, except for absolute change
scores where subjects on the lower-
carbohydrate/higher–monounsaturated
fat diet had a 2% increase in weight and a
16% decrease in plasminogen activator
inhibitor 1 (PAI-1) levels.
During the 24-h testing, TG proﬁles
tended to be lower in the lower-carbohy-
drate/higher–monounsaturated fat group
(see supplementary Fig. 1A and B in the
online appendix available at http://care.
diabetesjournals.org/cgi/content/full/dc08-
2322/DC1), while glycemic levels after
supper were higher in the higher-carbohy-
drate/lower-fat group. Since weight change
affects TG levels, analyses were repeated
with subjects maintaining stable weight
(2 kg) throughout the study (see supple-
mentary Fig. 2Aand Bin the online appen-
dix). Many signiﬁcantly lower TG levels
were observed in the lower-carbohydrate/
higher–monounsaturated fat group, result-
ing in a smaller TG area under the curve
(P  0.05).
CONCLUSIONS — In a sample of
nonobese adults with well-controlled,
uncomplicated type 1 diabetes on inten-
Table 1—Glycemic, anthropometric, blood pressure, and fasting plasma lipid measurements and oxidative, thrombotic, and inﬂammatory
markers throughout the dietary trial for the higher-carbohydrate/lower-fat diet group (n  15) and lower-carbohydrate/higher–
monounsaturated fat diet group (n  15)
Higher-carbohydrate/lower-fat diet
Lower-carbohydrate/higher–
monounsaturated fat diet
Baseline* 6 Months†
Absolute
change Baseline* 6 Months†
Absolute
change
A1C (%) 7.3  0.7 7.2  0.7 0.2  0.5 7.0  0.7 7.1  0.9 0.1  0.6
BMI (kg/m
2) 24.3  2.6 24.1  2.6 0.24  1.0‡ 24.3  2.7 24.8  2.7 0.56  0.6‡
Weight (kg) 71.1  13.7 70.3  13.1 0.83  3.0‡ 71.8  13.4 73.4  13.6 1.6  1.8‡
Body fat (%) 25.3  7.6 23.8  7.0 1.6  3.8‡ 23.9  7.6 25.3  7.4 1.4  2.1‡
Fat-free mass (%) 36.6  5.5 37.6  5.3 1.0  2.4 36.3  4.7 36.5  5.6 0.24  2.2
Systolic blood pressure (mmHg) 116  15 120  10 3.9  14.4 122  15 122  16 0.2  21.1
Diastolic blood pressure (mmHg) 72  77 7  8 4.7  11.0 78  77 5  8 2.6  8.9
TG (mmol/l) 0.72  0.30 0.86  0.55 0.14  0.46 0.68  0.34 0.65  0.20 0.03  0.22
Total cholesterol (mmol/l) 4.40  0.66 4.28  0.78 0.12  0.66 4.48  0.88 4.25  0.64 0.24  0.66
HDL cholesterol (mmol/l) 1.47  0.35 1.53  0.35 0.06  0.27 1.64  0.33 1.63  0.38 0.01  0.22
Total cholesterol–to–HDL cholesterol ratio 3.12  0.77 2.90  0.78 0.22  0.55 2.80  0.67 2.67  0.48 0.13  0.37
LDL cholesterol (mmol/l) 2.60  0.63 2.35  0.75 0.25  0.70 2.53  0.73 2.31  0.46 0.21  0.57
ApoB (g/l) 0.78  0.17 0.76  0.22 0.01  0.12 0.75  0.12 0.72  0.11 0.04  0.07
8-iso PGF (pg/ml) 239  147 267  167 27.9  132.6 243  132 210  138 32.1  68.3
PAI-1 (ng/ml) 55.0  23.2 69.2  23.1 14.2  24.5‡ 78.5  37.7 65.7  28.7 12.8  27.0‡
E-selectin (ng/ml) 22.5  14.7 21.7  13.9 0.8  3.5 23.8  15.5 25.0  14.5 1.2  3.0
sICAM-1 (ng/ml) 314  59 315  58 0.2  37 326  84 328  77 2.0  46
hsCRP-1 (g/ml) 7.6  8.2 9.9  12.3 2.3  10.9 6.8  5.4 5.1  5.9 1.7  4.8
TNF- (pg/ml) 1.2  0.5 1.5  0.8 0.3  0.8 1.4  0.5 1.4  0.9 0.1  0.8
Data are means  SD. *No signiﬁcant differences were observed between diet groups at baseline (P  0.05). †No signiﬁcant differences were observed between diet
groups at 6 months (P  0.05). ‡Signiﬁcantly different between diet groups for absolute change between baseline and 6 months (P  0.05). hsCRP, high-sensitivity
C-reactive protein; PGF, prostaglandins-F2-; sICAM, soluable intracellular adhesion molecule; TNF, tumor necrosis factor.
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carbohydrate/higher–monounsaturated
fat diet was found to have a positive effect
on thrombotic factor PAI-1 and no ad-
verse effect on lipid control. A small in-
creaseinBMIinthelower-carbohydrate/
higher–monounsaturatedfatgroupmay
beduetoalowermeal-inducedthermo-
genesis because of its higher fat content
(14); longer-term studies are needed.
In the higher-carbohydrate/lower-fat
group, where individuals had increased
carbohydrateintakeby	20%,thehigher
fasting TG levels are in keeping with an
associated increase of VLDL-TG produc-
tion, as shown in type 2 diabetes studies
(6–7).Inthelower-carbohydrate/higher–
monounsaturated fat group, fasting TG
levels remained steady, despite a small
weight gain. Insulin doses were unlikely
to have determined fasting TG levels,
given that the doses administered were
comparable in the two groups and appro-
priately adjusted to carbohydrate intake
in order to maintain A1C levels close to
the recommended range.
During the 24-h test period, higher
TG levels were observed in the higher-
carbohydrate/lower-fat group. The ﬁnd-
ing that “carbohydrate-induced lipemia”
rather than “fat-induced lipemia” (3) may
have a dominant inﬂuence on triglyceri-
demia in the diabetic state in day-to-day
conditions has clinical relevance. Our
subjects had normal TG values; further
research is warranted with individuals in
poor lipid control.
Higher glycemic levels after the high-
er-carbohydrate/lower-fat supper were
observed during the 24-h testing period,
despite appropriate adjustment of insulin
doses to carbohydrate meal content.
Lower glycemic levels after the higher–
monounsaturated fat supper meal may be
due to slower gastric emptying in the
presence of olive oil (15).
Limitations include small sample size
and short study duration. Our results are
in keeping with the American Diabetes
Association statement that it is unlikely
thatanoptimalmixofmacronutrientsex-
ists for the diabetic state (1).
In conclusion, a diet lower in carbo-
hydrate/higher in monounsaturated fat is
an appropriate nutrition therapy for type
1 diabetic individuals with good meta-
bolic and weight control.
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